Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer

Doxorubicin is the most effective anthracycline chemotherapy drug in the treatment of cancer, and it is an effective single agent in the treatment of non-small cell lung cancer (NSCLC). There is a lack of studies on the differentially expressed doxorubicin metabolism-related lncRNAs in NSCLC. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Qianyi, Zhang, Ming, Kong, Ying, Huang, Ziyuan, Zou, Zhuoheng, Xiong, Zhuolong, Xie, Xiaolin, Cao, Zitong, Situ, Wanyi, Dong, Jiaxin, Li, Shufang, Zhu, Xiao, Huang, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984793/
https://www.ncbi.nlm.nih.gov/pubmed/36879965
http://dx.doi.org/10.1016/j.heliyon.2023.e13811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984793/
https://www.ncbi.nlm.nih.gov/pubmed/36879965
http://dx.doi.org/10.1016/j.heliyon.2023.e13811

Ejemplares similares